Vivos (RDGL) Operating Leases (2025)
Vivos' (RDGL) quarterly Operating Leases came in at $88851.0 in Q4 2025.
Powered by 
Analysis
Vivos (RDGL) Operating Leases (2025) Analysis & Trends
Vivos has disclosed Operating Leases across 1 years of filings, most recently posting $88851.0 for Q4 2025.
- In Q4 2025, Operating Leases changed N/A year-over-year to $88851.0; the TTM figure through Dec 2025 stood at $88851.0 (changed N/A YoY), while the FY2025 annual figure was $88851.0, changed N/A from the prior year.
- Operating Leases came in at $88851.0 for Q4 2025 at Vivos.
- In the past five years, Operating Leases ranged from a high of $88851.0 in Q4 2025 to a low of $88851.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Vivos | 23.21 Mn | 23.21 Mn | - |